Valoración (Assay): Cumple con la especificación de valoración farmacopeica (normalmente ≥98,0% sobre base anhidra), confirmada mediante métodos analíticos de HPLC/valoración validados.
Purity: Pureza de grado farmacéutico conforme a la monografía farmacopeica aplicable (USP/EP/BP/ChP según corresponda) para esta sustancia activa.
Perfil de impurezas: Las impurezas relacionadas individuales y totales se controlan dentro de los límites ICH Q3A/Q3B y la monografía farmacopeica correspondiente.

Otra información

Descripción adicional:

GastroBarrier is a probiotic formulated with acid-resistant bacteria designed to act starting in the stomach. It was studied in patients taking proton pump inhibitors to help control a known side effect of these drugs, bacterial overgrowth. The strains L. rhamnosus LR06, L. pentosus LPS01, L. plantarum LP01, and L. delbrueckii subsp. delbrueckii LDD01 were chosen for their ability to counter specific pathogens, and two clinical studies measuring bacteria in gastric juice showed GastroBarrier significantly reduced bacterial overgrowth in PPI users.